Companies /Consumer Defensive

Altria Group Inc

NYSE: MO Tobacco
$68.87
▼ $0.62 (−0.89%) today
Markets closed · 4:54pm ET

Q1 2026 Earnings

Reported Apr 30, 2026, 7:05am ET · SEC source
$1.32
Beat +5.92%
EPS · est. $1.25
$5.4B
Beat +18.58%
Revenue · est. $4.6B
−10.4%
Trailing market
MO vs S&P since report
1 quarter
Consecutive EPS beats

Market Reaction

% change · around the report
0+3%+6%Apr 30May 1report 7:05am ETearnings+1.3%+6.4%
0+3%+6%Apr 30May 1earnings+1.3%+6.4%
MO +6.4%S&P 500 +1.3%
0+3%+6%Apr 30May 1report 7:05am ETearnings+1.7%+6.4%
0+3%+6%Apr 30May 1earnings+1.7%+6.4%
MO +6.4%NASDAQ +1.7%
−3%0+3%+6%Apr 29May 8report 7:05am ETearnings+3.0%−0.9%
−3%0+3%+6%Apr 29May 8earnings+3.0%−0.9%
MO −0.9%S&P 500 +3.0%
−3%0+3%+6%Apr 29May 8report 7:05am ETearnings+5.5%−0.9%
−3%0+3%+6%Apr 29May 8earnings+5.5%−0.9%
MO −0.9%NASDAQ +5.5%
+6.52%
Day of report
+2.62%
Next session
−4.97%
One week
−4.69%
30 days

S&P 500 over the same 30 days: +5.69%.

Did MO Beat Earnings? Q1 2026 Results

Altria Group delivered a strong beat on both lines in Q1 2026, extending its streak of consensus EPS beats to four consecutive quarters as the tobacco giant posted adjusted diluted EPS of $1.32, clearing the $1.25 consensus estimate by 5.92%, while revenue of $5.43 billion topped expectations by 18.58% and grew 20.1% year over year. The headline revenue surge was driven in large part by the introduction of contract manufactured export cigarettes, a new activity that added 610 million sticks to shipment volumes, alongside continued pricing strength in the smokeable products segment, where adjusted operating companies income rose 6.3% to $2.68 billion and margins expanded to 65.1%. Growth was partially offset by Marlboro's retail share slipping 1.4 points to 39.7% and mounting competition in nicotine pouches, where on!'s category share fell to 13.4%. Looking ahead, Altria reaffirmed its full-year 2026 adjusted diluted EPS guidance of $5.56 to $5.72, reflecting 2.5% to 5.5% growth, with management now expecting a more balanced earnings cadence across both halves of the year.

Key Takeaways
  • Higher pricing across smokeable and oral tobacco segments
  • Refunds of taxes and duties paid on imported cigarettes in 2026
  • Fewer shares outstanding contributing to adjusted diluted EPS growth
  • Marlboro strengthened its position in the premium cigarette segment with 59.5% share
  • on! nicotine pouch shipment volume grew 17.6%
  • Introduction of contract manufactured export cigarettes (610 million sticks)

“We delivered a strong start to the year, growing adjusted diluted EPS by 7.3% in the first quarter. Our highly cash-generative businesses supported significant returns to shareholders through dividends and share repurchases, while we continued to invest in support of our Vision.”

Altria CEO, on the earnings call

Forward Guidance & Outlook

Altria reaffirmed full-year 2026 adjusted diluted EPS guidance of $5.56 to $5.72, representing 2.5% to 5.5% growth from a 2025 base of $5.42. Following strong Q1 performance, the company now expects adjusted diluted EPS growth to be more balanced between the first half and second half of the year. The reaffirmed guidance incorporates the impact of moderated e-vapor industry growth on combustible and e-vapor product volumes and increased macroeconomic uncertainty facing adult nicotine consumers. Additional assumptions include a progressive increase in cigarette import and export activity over the course of the year, planned investments in contract manufacturing capabilities, the expectation that NJOY ACE does not return to the marketplace in 2026, reinvestment of anticipated cost savings from the Optimize & Accelerate initiative, and planned investments in support of the company's Vision.

MO YoY Financials

Q1 2026 vs Q1 2025 · SEC filings Q1 2025 Q1 2026
$0$2.0B$4.0B$4.5B$5.4BRevenue$3.2B$3.5BGross Profit$1.8B$3.0BOperating Income$1.1B$2.2BNet Income
$0$2.0B$4.0BRevenueGross ProfitOperating IncomeNet Income

MO Revenue by Segment

Smokeable Products$4.8B+2.9%
Oral Tobacco Products$669.0M+2.3%
E-Vapor Products

Figures from SEC filings and company reports. Not investment advice.